Unfortunately downhill since merger - Recensione dipendente - Dipendente anonimo presso IQVIA

2,0
30 apr 2018
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Unlimited career options and good growth potential in most areas, you learn a ton, they are a strong leader in most areas they conduct research in, especially clinical trial and real world evidence studies.

Svantaggi

Benefits and culture on a serious downhill slide since merger with IMS (from legacy Q perspective). Different areas of the company that overlap in services compete with each other rather than collaborate and this seems to be encouraged. All male leaders (very rare exceptions) at the top in an organization that is probably more than half female in ranks. Respect for medical and scientific expertise over selling data has slipped.

Esplora altre recensioni su IQVIA

1,0
30 giu 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Remote work option is nice to have

Svantaggi

Zero support from management, with employee development and team concerns often taking a back seat to other priorities. Morale continues to go downhill, and several colleagues exploring opportunities elsewhere or leaving the organization already. The culture is challenging, particularly around providing candid feedback, as employees often are tracker down and face negative repercussions and retaliations. Career advancement depends more on aligning with leadership preferences than on merit and performance. Would not recommend this company to those seeking a supportive environment with transparent growth opportunities. Overall, the culture is political and difficult to navigate.

Vedi recensioni per: Utile|Valutazione|Data|Tutto